Skip to main content
SPRO
NASDAQ Life Sciences

Spero Posts $44.3M Q3 Loss, Far Exceeding Prior Quarter's $9.6M

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1
Mkt Cap
$58.235M
52W Low
$0.961
52W High
$3.08
52W Position info
4.1% above low
Off High info
68% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

SPRO is trading near its 52-week low of $0.961 (4.1% above the low).

Summary

Spero reported a $44.3 million third-quarter loss, a sharp widening from the $9.6 million net loss it posted for Q2, with the wider loss tied to an SP001 licensing payment. The company has no product revenue and is funding itself off a $105 million royalty financing that management said extends cash runway into 2029, so the size of this quarter's loss matters more than usual for a name trading near its 52-week low. A Phase 2 trial is planned for Q2 2027. The loss lands alongside recent board turnover — Patrick Vink resigned November 10 and William Ho joined the board — and COO Timothy Keutzer's planned retirement at year-end. The company also has a $300 million shelf and a $100 million Jefferies at-the-market program in place, giving it a ready channel to raise equity if the burn continues at this pace.

At the time of this announcement, SPRO was trading at $1.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $58.2M. The 52-week trading range was $0.96 to $3.08. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

SPRO - Latest Insights

SPRO
Nov 12, 2026, 4:34 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.990
Real-time Price: $0.990 info
Change: $0 (0%) info
Market Cap: $58.235M info
SPRO
Aug 12, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.23
Real-time Price: $0.990 info
Change: -$0.240 (-20%) info
Market Cap: $58.235M info
SPRO
Aug 12, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.23
Real-time Price: $0.990 info
Change: -$0.2395 (-19%) info
Market Cap: $58.235M info
SPRO
Jul 14, 2026, 6:30 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.11
Real-time Price: $0.990 info
Change: -$1.12 (-53%) info
Market Cap: $58.235M info
SPRO
Jul 14, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.09
Real-time Price: $0.990 info
Change: -$1.10 (-53%) info
Market Cap: $58.235M info